Last updated: 2 months ago
GT Biopharma, Inc. 2024 Financial Report: Hold Amid Losses & R&D Investments
Explore GT Biopharma's 2024 financial performance, highlighting a $13.2M loss, R&D focus, and strategic recommendations for investors.
Posts With Tag immune-oncology
Showing 1 - 1 of 1 Post